In 2023, the global radiotheranostics market reached a valuation of USD 8.5 billion. Looking ahead, IMARC Group projects it will grow to USD 24.5 billion by 2032, with a CAGR of 12.4% from 2024 to 2032. This growth is driven by factors such as the increasing prevalence of cancer, ongoing technological advancements, expanding research and development (R&D) initiatives, supportive government policies, and rising awareness of radiotheranostics among individuals. Visit us: https://www.imarcgroup.com/rad....iotheranostics-marke